Stephen L. Silvestro - Mar 1, 2022 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Commercial Officer
Signature
/s/ Stephen Silvestro
Stock symbol
OPRX
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 03:46 PM
Previous filing
Dec 21, 2021
Next filing
Aug 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Stock Option Award $0 +11.7K $0.00 11.7K Mar 1, 2022 Common Stock 11.7K $43.24 Direct F1
transaction OPRX Restricted Stock Units Award $0 +5.78K $0.00 5.78K Mar 1, 2022 Common Stock 5.78K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
F3 The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.